Hims & Hers Health, Inc. (HIMS, Financial) has announced that Melissa Baird, its Chief Operating Officer, plans to shift into an advisory position within the company in the upcoming months. This change comes after Baird's extensive career with the organization.
The exact timing of Baird's departure from her current role as COO has not been finalized. However, she intends to stay on until a suitable successor is chosen, onboarded, and familiarized with the company's operations. This approach is intended to ensure a seamless transition.
Upon moving to an advisory capacity, Baird and Hims & Hers will formalize a long-term agreement. This arrangement aims to allow the company to continue benefiting from Baird’s expertise, which has been instrumental to its operations over the years.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for Hims & Hers Health Inc (HIMS, Financial) is $44.50 with a high estimate of $85.00 and a low estimate of $22.00. The average target implies an upside of 72.20% from the current price of $25.84. More detailed estimate data can be found on the Hims & Hers Health Inc (HIMS) Forecast page.
Based on the consensus recommendation from 15 brokerage firms, Hims & Hers Health Inc's (HIMS, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Hims & Hers Health Inc (HIMS, Financial) in one year is $32.38, suggesting a upside of 25.31% from the current price of $25.84. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Hims & Hers Health Inc (HIMS) Summary page.
